BMY - Bristol-Myers Squibb Co.
Close
49.95
0.230 0.460%
Share volume: 9,590,861
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$49.72
0.23
0.46%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-26 | 2023-02-14 | 2023-04-27 | 2023-07-27 | 2023-10-26 | 2024-02-13 | 2024-04-25 | 2024-07-26 | |
| Assets | |||||||||
| Total Assets | 98.196 B | 96.820 B | 94.281 B | 93.489 B | 91.263 B | 95.159 B | 99.031 B | 94.646 B | |
| Current Assets | 26.796 B | 27.273 B | 27.086 B | 28.074 B | 27.632 B | 31.770 B | 28.669 B | 26.890 B | |
| Inventories | 2.074 B | 2.339 B | 2.605 B | 2.364 B | 2.436 B | 2.662 B | 2.985 B | 3.077 B | |
| Other Current Assets | 5.918 B | 5.647 B | 5.105 B | 6.815 B | 7.153 B | 5.852 B | 5.565 B | 5.735 B | |
| Short Term Investments | 5.918 B | 5.647 B | 5.105 B | 6.815 B | 7.153 B | 5.852 B | 5.565 B | 5.735 B | |
| Total Receivables | 9.613 B | 9.886 B | 10.054 B | 10.112 B | 10.304 B | 10.921 B | 10.447 B | 11.423 B | |
| Current Cash | 9.027 B | 9.253 B | 9.269 B | 8.730 B | 7.685 B | 12.280 B | 9.670 B | 6.653 B | |
| Total Non-current Assets | 71.400 B | 69.547 B | 67.195 B | 65.415 B | 63.631 B | 63.389 B | 70.362 B | 67.756 B | |
| Property Plant Equipment | 6.035 B | 6.255 B | 6.279 B | 6.355 B | 6.481 B | 6.646 B | 6.750 B | 6.845 B | |
| Other Assets | 1.844 B | 1.479 B | 1.537 B | 1.757 B | 2.290 B | 2.281 B | 2.727 B | 2.754 B | |
| Intangible Assets | 38.179 B | 35.859 B | 33.569 B | 31.303 B | 28.950 B | 27.072 B | 32.760 B | 29.428 B | |
| Goodwill | 21.112 B | 21.149 B | 21.162 B | 21.163 B | 21.147 B | 21.169 B | 21.738 B | 21.732 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 98.196 B | 96.820 B | 94.281 B | 93.489 B | 91.263 B | 95.159 B | 99.031 B | 94.646 B | |
| Total liabilities | 65.525 B | 65.759 B | 62.457 B | 61.516 B | 62.265 B | 65.729 B | 82.541 B | 77.631 B | |
| Total current liabilities | 18.930 B | 21.890 B | 19.085 B | 20.150 B | 23.462 B | 22.262 B | 25.822 B | 23.265 B | |
| Accounts Payable | 2.595 B | 3.040 B | 3.194 B | 3.069 B | 2.813 B | 3.259 B | 3.539 B | 3.751 B | |
| Other liabilities | 5.503 B | 4.980 B | 4.907 B | 4.162 B | 4.306 B | 4.464 B | 4.701 B | 3.088 B | |
| Current long term debt | 2.132 B | 4.264 B | 2.752 B | 3.020 B | 5.467 B | 3.119 B | 6.190 B | 3.531 B | |
| Long term debt | 36.966 B | 35.056 B | 35.078 B | 34.656 B | 32.137 B | 36.653 B | 49.487 B | 48.858 B | |
| Other liabilities | 5.503 B | 4.980 B | 4.907 B | 4.162 B | 4.306 B | 4.464 B | 4.701 B | 3.088 B | |
| Minority interest | 63.000 M | 57.000 M | 62.000 M | 57.000 M | 64.000 M | 55.000 M | 58.000 M | 54.000 M | |
| Total Shareholder equity | 32.671 B | 31.061 B | 31.824 B | 31.973 B | 28.998 B | 29.430 B | 16.490 B | 17.015 B | |
| Common stock | 2.133 B | 2.108 B | 2.099 B | 2.093 B | 2.057 B | 2.027 B | 2.023 B | 2.027 B | |
| Retained earnings | 24.675 B | 25.503 B | 26.568 B | 27.449 B | 28.218 B | 28.766 B | 15.640 B | 16.103 B |